Get the Stockscreener App
8.61
13.34%
1.02
Relay Therapeutics Inc stock is traded at $8.61, with a volume of 1.32M.
It is up +13.34% in the last 24 hours and up +0.50% over the past month.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
See More
Previous Close:
$7.59
Open:
$7.57
24h Volume:
1.32M
Relative Volume:
0.60
Market Cap:
$1.49B
Revenue:
$25.55M
Net Income/Loss:
$-341.97M
P/E Ratio:
-3.075
EPS:
-2.8
Net Cash Flow:
$-304.44M
1W Performance:
+16.09%
1M Performance:
+0.50%
6M Performance:
+130.01%
1Y Performance:
+82.25%
1-Day Range:
$7.42
$8.62
1-Week Range:
$7.36
$8.62
52-Week Range:
$1.775
$9.04
Relay Therapeutics Inc Stock (RLAY) Company Profile
Name
Relay Therapeutics Inc
Sector
Industry
Phone
617-370-8837
Address
60 HAMPSHIRE STREET, CAMBRIDGE
Compare RLAY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
8.62 | 1.32B | 25.55M | -341.97M | -304.44M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.44 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
768.51 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
865.92 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
358.61 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
335.92 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-04-25 | Resumed | Guggenheim | Buy |
| Apr-17-25 | Initiated | Wells Fargo | Equal Weight |
| Sep-10-24 | Resumed | Goldman | Buy |
| Sep-10-24 | Upgrade | Jefferies | Hold → Buy |
| Sep-10-24 | Downgrade | Oppenheimer | Outperform → Perform |
| May-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Apr-20-23 | Upgrade | Jefferies | Underperform → Hold |
| Apr-19-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-13-23 | Initiated | Raymond James | Outperform |
| Feb-03-23 | Initiated | Oppenheimer | Outperform |
| Sep-30-22 | Initiated | Barclays | Equal Weight |
| Sep-02-22 | Initiated | Stifel | Buy |
| Jun-06-22 | Initiated | Jefferies | Underperform |
| Feb-01-22 | Initiated | Berenberg | Buy |
| Jul-21-21 | Initiated | BofA Securities | Buy |
| Dec-15-20 | Reiterated | H.C. Wainwright | Buy |
| Dec-08-20 | Initiated | JMP Securities | Mkt Outperform |
| Nov-05-20 | Initiated | H.C. Wainwright | Buy |
| Aug-10-20 | Initiated | Cowen | Outperform |
| Aug-10-20 | Initiated | Goldman | Buy |
| Aug-10-20 | Initiated | Guggenheim | Buy |
| Aug-10-20 | Initiated | JP Morgan | Neutral |
View All
Relay Therapeutics Inc Stock (RLAY) Latest News
Oppenheimer Upgrades Relay Therapeutics (RLAY) - Nasdaq
Oppenheimer Upgrades Relay Therapeutics (RLAY) with Positive Out - GuruFocus
Oppenheimer upgrades Relay Therapeutics stock rating on gedatolisib concerns By Investing.com - Investing.com Canada
Relay Therapeutics (RLAY) Upgraded by Oppenheimer, Price Target Set at $14.00 | RLAY Stock News - GuruFocus
Relay Therapeutics stock rises after Oppenheimer upgrade By Investing.com - Investing.com Nigeria
Relay Therapeutics stock rises after Oppenheimer upgrade - Investing.com
Oppenheimer Upgrades Relay Therapeutics to Outperform From Market Perform, Price Target is $14 - marketscreener.com
Dip Buying: Can Relay Therapeutics Inc expand into new markets2025 Biggest Moves & Long-Term Growth Stock Strategies - baoquankhu1.vn
Published on: 2026-01-24 18:03:27 - baoquankhu1.vn
Analyst Calls: Will Relay Therapeutics Inc. stock hit new highs in YEARSell Signal & Technical Confirmation Alerts - baoquankhu1.vn
Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Performance Recap: Can Relay Therapeutics Inc keep up with sector leadersWeekly Trade Review & Growth Focused Entry Point Reports - baoquankhu1.vn
Decliners Report: Can Relay Therapeutics Inc sustain its profitabilityJuly 2025 Movers & Weekly Top Gainers Trade List - baoquankhu1.vn
Aug Intraday: Will Relay Therapeutics Inc stock hit new highs in YEAR2025 Technical Overview & Smart Swing Trading Alerts - baoquankhu1.vn
Relay Therapeutics, Inc. (RLAY) Stock Analysis: A Biotech Play with Potential 91% Upside Driven by Analyst Confidence - directorstalkinterviews.com
Guidance Update: How does FingerMotion Inc compare to its peersNew Guidance & Fast Moving Stock Watchlists - baoquankhu1.vn
Bearish Setup: What is the dividend yield of CPSSJuly 2025 Chart Watch & Fast Gaining Stock Reports - baoquankhu1.vn
Market Recap: Can Relay Therapeutics Inc keep up with sector leadersTrade Exit Report & Community Consensus Stock Picks - baoquankhu1.vn
Why Relay Therapeutics Inc. stock could outperform in 2025Footwear buying guidance for daily running and walking routines focuses on joint friendly cushioning, making it a solid option for daily use. - ulpravda.ru
Aug Reactions: Can Relay Therapeutics Inc keep up with sector leadersEarnings Overview Summary & Weekly High Potential Alerts - baoquankhu1.vn
Aug Levels: Is Relay Therapeutics Inc stock showing strong momentumMarket Rally & Technical Confirmation Trade Alerts - baoquankhu1.vn
Have Relay Therapeutics Insiders Been Selling Stock? - simplywall.st
Is Relay Therapeutics Inc. stock a contrarian buyDollar Strength & Real-Time Stock Movement Alerts - Улправда
Will Relay Therapeutics Inc. stock deliver shareholder valueTrade Entry Report & Technical Analysis for Trade Confirmation - Улправда
Will Relay Therapeutics Inc. stock benefit from sector rotationQuarterly Risk Review & Low Risk Profit Maximizing Plans - ulpravda.ru
Will Relay Therapeutics Inc. stock split attract more investors2025 Technical Overview & Consistent Income Trade Recommendations - Улправда
How strong is Relay Therapeutics Inc. stock balance sheetWeekly Volume Report & Daily Oversold Bounce Ideas - ulpravda.ru
Why Relay Therapeutics Inc. stock could benefit from AI revolutionWall Street Watch & Weekly High Conviction Trade Ideas - Улправда
How Relay Therapeutics Inc. stock performs in rate cut cyclesRisk Management & Low Drawdown Trading Techniques - ulpravda.ru
CEO Change: Will Relay Therapeutics Inc. stock pay special dividendsEarnings Recap Summary & Daily Entry Point Trade Alerts - ulpravda.ru
Is Relay Therapeutics Inc. stock a buy before product launchesEnergy Sector Updates & Free Professional Investment Consultations - Улправда
Insider Selling: Relay Therapeutics (NASDAQ:RLAY) CEO Sells $337,573.76 in Stock - MarketBeat
User | guymondailyherald.comRelay Therapeutics, Inc.Common Stock (Nasdaq:RLAY) Stock Quote - FinancialContent
Relay Therapeutics Q3 2025 Earnings Preview - MSN
Relay Therapeutics announces analysis of data for zovegalisib - MSN
What makes Relay Therapeutics Inc. stock attractive to growth funds2026 world cup usa national team round of 32 goalkeepers low block defense knockout prediction guide - ulpravda.ru
Relay Therapeutics CEO Sanjiv Patel sells $818,399 in stock - MSN
Relay Therapeutics, Inc. (RLAY) Stock Analysis: Unpacking the 72.58% Potential Upside in Precision Medicine - DirectorsTalk Interviews
Why Relay Therapeutics Stock Rocketed Nearly 15% Higher This Week - MSN
Aug Action: What makes Relay Therapeutics Inc. stock attractive to growth fundsPortfolio Value Report & Weekly High Conviction Trade Ideas - moha.gov.vn
Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Take Profit: Can Relay Therapeutics Inc. stock hit record highs again2025 Valuation Update & Precise Trade Entry Recommendations - moha.gov.vn
Will Relay Therapeutics Inc. stock gain from strong economyFibonacci Retracement Levels & Analyze Your Portfolio Risk in Seconds - bollywoodhelpline.com
Relay Therapeutics (NASDAQ:RLAY) Shares Up 4.9%Here's What Happened - MarketBeat
Congress Asset Management Co. Has $2.13 Million Stock Holdings in Relay Therapeutics, Inc. $RLAY - MarketBeat
Relay Therapeutics signals slowdown to recharge after busy year - Traders Union
Will Relay Therapeutics Inc stock pay special dividendsMarket Sentiment Report & Verified Technical Signals - moha.gov.vn
Zovegalisib’s Consistent Efficacy Across Tough Subgroups Could Be A Game Changer For Relay (RLAY) - simplywall.st
What sentiment indicators say about Relay Therapeutics Inc. stockQuarterly Market Summary & High Win Rate Trade Alerts - Улправда
Can Relay Therapeutics Inc. stock hit analyst price targets2025 Sector Review & AI Enhanced Trading Alerts - Улправда
Is Relay Therapeutics Inc. stock attractive for passive investors2025 Biggest Moves & Risk Managed Investment Entry Signals - Улправда
Relay Therapeutics Inc Stock (RLAY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Relay Therapeutics Inc Stock (RLAY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Patel Sanjiv | President and CEO |
Nov 03 '25 |
Sale |
7.00 |
62,073 |
434,511 |
703,215 |
| Rahmer Peter | See remarks |
Oct 29 '25 |
Sale |
7.50 |
21,394 |
160,455 |
337,469 |
| Rahmer Peter | See remarks |
Oct 28 '25 |
Sale |
7.29 |
19,135 |
139,494 |
358,863 |
| Catinazzo Thomas | Chief Financial Officer |
Oct 28 '25 |
Sale |
7.29 |
21,664 |
157,931 |
313,631 |
| Bergstrom Donald A | President, R&D |
Oct 28 '25 |
Sale |
7.29 |
30,897 |
225,239 |
521,823 |
2.05%
0.66%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):